Mike Stone

2.5k total citations · 1 hit paper
48 papers, 1.7k citations indexed

About

Mike Stone is a scholar working on Orthopedics and Sports Medicine, Surgery and Oncology. According to data from OpenAlex, Mike Stone has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Orthopedics and Sports Medicine, 21 papers in Surgery and 12 papers in Oncology. Recurrent topics in Mike Stone's work include Bone health and osteoporosis research (30 papers), Hip and Femur Fractures (17 papers) and Bone health and treatments (12 papers). Mike Stone is often cited by papers focused on Bone health and osteoporosis research (30 papers), Hip and Femur Fractures (17 papers) and Bone health and treatments (12 papers). Mike Stone collaborates with scholars based in United Kingdom, United States and Netherlands. Mike Stone's co-authors include Antony Johansen, Stuart H. Ralston, Peter Selby, M.W.J. Davie, Ronan A Lyons, D. J. Hosking, Eugène McCloskey, Cyrus Cooper, Sarah Jones and Su Vui Lo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cochrane Database of Systematic Reviews.

In The Last Decade

Mike Stone

47 papers receiving 1.6k citations

Hit Papers

UK clinical guideline for the prevention and treatment of... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Stone United Kingdom 18 964 540 489 272 242 48 1.7k
Pierre Delmas United Kingdom 5 1.7k 1.7× 584 1.1× 657 1.3× 454 1.7× 328 1.4× 6 2.2k
Patrick Burkhardt Germany 5 1.7k 1.7× 575 1.1× 665 1.4× 446 1.6× 319 1.3× 6 2.2k
C Cooper United States 5 1.7k 1.7× 572 1.1× 705 1.4× 450 1.7× 321 1.3× 8 2.4k
Alun Cooper United Kingdom 13 1.1k 1.2× 506 0.9× 780 1.6× 339 1.2× 147 0.6× 21 1.7k
P Meunier Belgium 6 1.7k 1.8× 581 1.1× 676 1.4× 447 1.6× 335 1.4× 19 2.3k
M. Sosa Henríquez Spain 24 796 0.8× 291 0.5× 527 1.1× 231 0.8× 559 2.3× 150 1.7k
Jacqueline Halton Canada 24 365 0.4× 328 0.6× 352 0.7× 190 0.7× 119 0.5× 56 2.1k
A Tosteson United States 8 2.0k 2.1× 663 1.2× 967 2.0× 514 1.9× 377 1.6× 10 2.7k
D.A. Hanley Canada 7 1.1k 1.1× 349 0.6× 723 1.5× 231 0.8× 149 0.6× 9 1.5k
S. A. Jamal Canada 18 1.7k 1.8× 530 1.0× 971 2.0× 320 1.2× 281 1.2× 23 2.4k

Countries citing papers authored by Mike Stone

Since Specialization
Citations

This map shows the geographic impact of Mike Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Stone more than expected).

Fields of papers citing papers by Mike Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Stone. The network helps show where Mike Stone may publish in the future.

Co-authorship network of co-authors of Mike Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Stone. A scholar is included among the top collaborators of Mike Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Stone. Mike Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lane, Joseph M., Bente Langdahl, Mike Stone, et al.. (2024). Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis International. 35(7). 1195–1204. 4 indexed citations
2.
Javaid, M K, Xavier L Griffin, D. Stephens, et al.. (2018). Service level predictors of bone treatment recommendations after a fragility fracture: Baseline findings from the first UK patient level Fracture Liaison Service Audit. Journal of Bone and Mineral Research. 33. 398–398. 1 indexed citations
3.
Evans, Louis, et al.. (2015). Hyperpharmacotherapy in ageing cystic fibrosis patients: The first report of an atypical hip fracture. SHILAP Revista de lepidopterología. 16. 148–150. 4 indexed citations
4.
Evans, B. A. J., A.B. Cox, Stephen J. Paisey, et al.. (2014). Preclinical Assessment of a New Magnetic Resonance-based Technique for Determining Bone Quality by Characterization of Trabecular Microarchitecture. Calcified Tissue International. 95(6). 506–520.
6.
Clark, Emma, Eugène McCloskey, Mike Stone, et al.. (2009). Lateral back pain identifies prevalent vertebral fractures in post-menopausal women: cross-sectional analysis of a primary care-based cohort. Lara D. Veeken. 49(3). 505–512. 15 indexed citations
7.
Bolton, Charlotte E., Rebecca Cannings‐John, P. Edwards, et al.. (2008). What community measurements can be used to predict bone disease in patients with COPD?. Respiratory Medicine. 102(5). 651–657. 14 indexed citations
8.
Cox, Helen, Suezann Puffer, Veronica Morton, et al.. (2007). Educating nursing home staff on fracture prevention: a cluster randomised trial. Age and Ageing. 37(2). 167–172. 44 indexed citations
9.
Masud, Tahir, David Torgerson, Mike Stone, et al.. (2006). A general practice audit of postmenopausal women at high fracture risk and its influence on falls burden: The osteoporosis nurse initiative programme (ONI). Osteoporosis International. 17. 2 indexed citations
10.
Tobias, Jonathan H., Linda Hunt, Eugène McCloskey, et al.. (2006). Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporosis International. 18(1). 35–43. 39 indexed citations
11.
Boonen, Steven, René Rizzoli, P. J. Meunier, et al.. (2004). The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporosis International. 15(7). 511–9. 126 indexed citations
12.
Stone, Mike, et al.. (2004). An analysis of an open access general practitioner bone densitometry service. International Journal of Clinical Practice. 58(3). 300–305. 4 indexed citations
13.
Johansen, Antony, et al.. (2003). Seasonal variation in the incidence of wrist and forearm fractures, and its consequences. Injury. 34(3). 219–222. 56 indexed citations
14.
Selby, Peter, M.W.J. Davie, Stuart H. Ralston, & Mike Stone. (2002). Guidelines on the management of Paget’s disease of bone*. Bone. 31(3). 366–373. 149 indexed citations
15.
Johansen, Antony, et al.. (2000). Trauma in elderly people: what proportion of fractures are a consequence of bone fragility?. Archives of Gerontology and Geriatrics. 29(3). 215–221. 7 indexed citations
16.
Johansen, Antony & Mike Stone. (1997). The effect of ankle oedema on bone ultrasound assessment at the heel. Osteoporosis International. 7(1). 44–47. 48 indexed citations
17.
Johansen, Antony, et al.. (1997). Reliability of parathyroid hormone measurements in the period immediately following hip fracture. Age and Ageing. 26(3). 175–178. 9 indexed citations
18.
Johansen, Antony, et al.. (1996). Bisphosphonates and the Treatment of Bone Disease in the Elderly. Drugs & Aging. 8(2). 113–126. 12 indexed citations
19.
Stone, Mike & D. J. Hosking. (1991). Treatment of osteoporosis: current and future.. Annals of the Rheumatic Diseases. 50(10). 663–665. 5 indexed citations
20.
Hosking, D. J., Mike Stone, & John Foote. (1990). Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy. European Journal of Clinical Pharmacology. 38(1). 37–41. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026